GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (NAS:LVTX) » Definitions » Current Accrued Expense

LAVA Therapeutics NV (LAVA Therapeutics NV) Current Accrued Expense : $3.85 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is LAVA Therapeutics NV Current Accrued Expense?

LAVA Therapeutics NV's Current Accrued Expense for the quarter that ended in Mar. 2024 was $3.85 Mil.

LAVA Therapeutics NV's quarterly Current Accrued Expense declined from Sep. 2023 ($5.85 Mil) to Dec. 2023 ($4.29 Mil) and declined from Dec. 2023 ($4.29 Mil) to Mar. 2024 ($3.85 Mil).

LAVA Therapeutics NV's annual Current Accrued Expense increased from Dec. 2021 ($1.57 Mil) to Dec. 2022 ($7.79 Mil) but then declined from Dec. 2022 ($7.79 Mil) to Dec. 2023 ($4.29 Mil).


LAVA Therapeutics NV Current Accrued Expense Historical Data

The historical data trend for LAVA Therapeutics NV's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LAVA Therapeutics NV Current Accrued Expense Chart

LAVA Therapeutics NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Current Accrued Expense
0.75 1.27 1.57 7.79 4.29

LAVA Therapeutics NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.03 11.63 5.85 4.29 3.85

LAVA Therapeutics NV Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


LAVA Therapeutics NV Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of LAVA Therapeutics NV's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


LAVA Therapeutics NV (LAVA Therapeutics NV) Business Description

Traded in Other Exchanges
Address
Yalelaan 62, Utrecht, UT, NLD, 3584 CM
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.

LAVA Therapeutics NV (LAVA Therapeutics NV) Headlines